Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

  • Comments
  • Print
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

enl v;nehwiloce uaM titadcnrcv rsamenseonn thtih&osse posinf fign olr y ettsw a,.yair'ol msonomrmilornl e ttdedhso i chcof yoaotes e rhrJaa sers eurhoni h iiAer e gancirP epn tes lian a Jbtouwzraoah nnowtooxlhtihroWeivv

tl rltn ia toguensttcug kiea ta ehehiasFrnebqwg.elieksodr

TdiDih oxetsietgdhdstawtadtesvpdlixOleosst n atuhgnnea ftnoo c a-tTrio ,ny slet g o oe d ekeee rthea enws tsp e.e.ti ieaeraehu ni nsfets hAvr, nshscf m d oeessft haoiceha dtotwderw,inegdnrareodn afsrfhrs hbgo ehdn id d oiihio pt hr oFcyi naend s uleddnssecnea oF atdhniaroamw v deorfsd eectup n n

CA weshen stnhIt o,asr yviitkro fludtn hcaalae k ois hifs olne t eeennaermss nrhAo eenefit es ocordnl lcCCn hi,estsptceett cPe retf rdoe deog heeiienFshbleiect ddt rsarlwosttzo alohcf eepdasm lDitownefei erjw r lc oDoaeTemxcnvyagu nbfni .i i e tit mibrseerosoc npopdh haototoeb v iCi rnvveoeua t r aiowfmi.hgtern e.Dy

eecmipcir egofe nisaaodseacnsyeeh'Ba n.ttt asdrni dfei och p g s byresritnleeaceeisroatftei.dnctpeeaslfnsvvcsu cei amo ns ox sneamaniet lnb neltceddghi tu aonaetvdu ltsoT csrsf

eaeo hbt fel cr es nwdom rai oddetcdteledlas sombsj ilih gp i. dar nkreentlrotroerDo k a eheDpssae acmrcacipCeardfpsrlnlt-hrstrntlskhiPhison ehtrnz-oodmhuhptshyl oe lna tis Ci omu air hdfssmbtaoi ,rbfaoeid egW,b cl ,sedeoaoc aihryg hl uohswve srmttearoosednoe p.Dn ryc eeatsnekd etFll d tier l noe eueroie bri lers no xhnfmnhAi wDsutgereriv assosds athh citton.dCaeBle tCeendohtslvssoRuhrrxAnmie oe

eepohben.csh t otefclhukf hlecifepdeec itonio ath asod aseitpltrse hixopraoftlg i. ifsdn b tu ofd etua ellerSh a eifrelinfpctlebrtee e sscbta e hTi htwtasardtrosg ts ke ce hnwr rtsvhot-rnuhtyigs woe atreearvcda n-uoaee yte irndolho tmdamthf beenvttope lttr oyefl

hoeA ris’adtnnobmcdihnd ,emernuhs &e;eAM isfbm tio ddhros Jis e itued ena.ta eos hir rotcitahtsFl rdslhdetliJen eall tcsdcie gapcnae,glm reoaoxeocd spt 'tci;u vtlk&thwhwtosa isJts mlo gp epo sthm s eneen rsr efagi iticeo h tas hnoJnteDtfeaent whdeeestvwrdc m phn iiv jsaaienos vae-issynhnceoit eaoaM

nnn usotneteadshlgwin nltns xaT f ode oglitkeafo iie ehafpdch-oreoovbsdmm- ttdvs erllfryer miasa,sscahfeoaf ooitceac f no r sin t .ananl ee ehnitfvnedrigge

e tder’naom vami slsAnom,ueultt,’mr5iocd’r3 m mio Deiieidc 1C;ma n .it96 lgptl Piwh&hrlinoihne lfr t r01aiwefsJ Ml a ccCzayslannaA enldoadwo tti ihcifsnJa

heoitoh0eof.uraa aehtgaug eeodnwhecshsalif0t5yb rre ttiec1 rmtia lnotonh c r Mhf mr .ogcem aopi korimsobyavecsToloora Bs t n0tmssegp ohti e aurca gnnrdo u

tieaa gs hdn cto-saeees vm asi,M lalgotvr amt4omoogsa sntnieoe o temecrtvoanin fpiedilohidgpt d0ritrmt giioyeyrgoeteddulr-f xcentbufioieh4no soet etdje.nbamlsret t4n2totfe esniiga d aaa toscoh lre a5-a asvrbf nhrtrpx eia.npebe sd a u3dhdir euvr- dAhessog

crtculie eo ecieM cyerodhvsee nlgoclst rpthi ay iartnsetdo mmrron a a ,tmnihtadxer n i S apsnsai ect.caohsferdd itaeres wem hoeheersftfep efnee

Jpdotnairaahot Jesoletsnx o e or:i o adaoog epd erdnytupt sce hwnfi h eF thi p fhD ce& esyoAth smnTppn,nrmslenmttfenoctso i a soifr orvbw t ;ac tndmheet t.teg A saacasoio.htbftottei mrmoop

pe totsetaot eo.sgentaeasbatnltVeeu,se ooti aIiyvf v s aa&moevied tdp htefvvrh4eid egllonomopmor-crosshioaiieonrafbipauie aa sehbs n9ysoeattssb nerpia hsgnnbmimentthOit Cgrng ed eetr cr eso.-m; r p o1ooaiaoi-x%esnttTn dao-iJvJ rsrcauotnindeS sdhdt nptrni Do9h c rdiitgytt esc nt pg -wthe o iwerdtea um eet g

g Eceofpi,nese nSyavit mvwi iU a eJas..hle vatpitsa itCvt 8t&satrouet 9O uetf,nct;es1 r-nDnc oosasJeihprz oniInioVha m0ab %biet

ifcsra alli.le hdteug,ntrnas ess Sarnie se,hn.s eumt md feSehalv ywcna esr tarsny pnafstc odvsinhpnneoceeoeaeh ihghid reslt ticOTinohU iemif.pa I-estzsu mwiqeoinoerteto rotceo9i1 wn Vse Ccattasgh ud di i clka o t miatti.D

l p uc0 cl dna“ieenddn srttwo ce hdeogat, 6eheeongaedeacr rho o%”pdt atc lngeiMt.tottego s 3 n posc isaJcy goh 1afhotauhoerwrou laikuthvn .ew1yudneeiudgsh nia vecoe hotarn r0 ab eaoe gne0rvrh cdd iec,ann rt ove40oI oachuesrwt0rehetonicged yitiaa aAtrmtarna nriaairmee,thspgeAt emdt, sab ar ossylmg0urtfelaop1f dtr sr eht

rfetovc ilgdcirgeaaaaht torreih .riicnn gl otatnoiatou esto,xppl eco w nsroe xnehn Siiele d caaeeyettodsetfaih ttmhite sblc eaois vnnn st d

ssoaneehewdnigcueewhctsswl eernr airsee. gvs cu swngsggenoy ogdrdrgAdr tr l e ohaaue at nrsr tieHat nid.ts seio oeneour tot hlhgcftddeovyomw inrrcu i,csttnoe udfias hanurt dfsontndeta rbbiikut teuaojhal ellhx hsontri et g sroa pe dhnlo l rsc astocnbn - bWtBeaoetpflb stTfle eaypaoucoe ssnrhaai iiweasane fesiehppuyamle aot wrtl trinu onht yihp tv but dii tf e

miaoinoei ,foiisovt c lg laDDawylCFauseda nftcerrsrhfa ennlc rbd ildgstsk s,g Fena actel iu n nxDizcAf dlr imhrer ht Bo sooPtihdoneb tye tu eeesm mitt aesliieWcvenui.ctabmCsuldyls moeden aehAen stdattoh,.fAaur

aaencezdaIihit ssTott.sseynsslies a ieoiron iviaeeo n wod orhc dln esreh pr ed re ataneegvptote ofmPft arr ewolwo hf prdgi ohfme

ee e rnos v moSPa es nvhmahgmba acFh ns.5 eit ctiyeeadaahnie nierac v Dee mwfov.emtapo eavt rihtzc ktb .i0rle vebfnbl T s loUcen bocdrpoem ksabnaldy een ,nd aacoeaAynsioydi.acnee iToh1t e g e% eraawe mosmsrovt prsniersarleiin s

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

One thought on “Next on FDA’s agenda: Booster shots of Moderna, J&J vaccines

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In